FDA clears AngioDynamics Auryon XL Catheter to treat Peripheral Arterial Disease

AngioDynamics announced that the United States Food and Drug Administration FDA has cleared the Auryon XL Catheter, a 225-cm radial access catheter, for use with the Auryon Atherectomy System in the treatment of Peripheral Arterial Disease PAD…”Radial access is more than an entry point; it’s a transformative expressway to enhanced patient outcomes,” said Ankur Lodha, M.D., interventional cardiologist at Cardiovascular Institute of the South located in Lafayette, Louisiana. “With an innovative design and its ease-of-use, the Auryon XL Catheter brings significant advancements to radial procedures as the first non-orbital atherectomy device – setting a new standard for laser atherectomy technology.” …Following FDA 510(k) clearance, AngioDynamics initiated a limited market release of the Auryon XL Catheter in the United States in January 2024 and expects to enter full market release in February 2024.